Venous thromboembolism in patients discharged after COVID-19 hospitalization
MM Engelen, C Vandenbriele… - … in thrombosis and …, 2021 - thieme-connect.com
Background Venous thromboembolism (VTE) is a frequent complication of COVID-19, so
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …
that the importance of adequate in-hospital thromboprophylaxis in patients hospitalized with …
Different anticoagulant regimens, mortality, and bleeding in hospitalized patients with COVID-19: a systematic review and an updated meta-analysis
We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …
no anticoagulation was associated with decreased risk of death among patients admitted to …
Diagnostic value of D-dimer in COVID-19: a meta-analysis and meta-regression
H Zhan, H Chen, C Liu, L Cheng… - Clinical and Applied …, 2021 - journals.sagepub.com
The prognostic role of hypercoagulability in COVID-19 patients is ambiguous. D-dimer, may
be regarded as a global marker of hemostasis activation in COVID-19. Our study was to …
be regarded as a global marker of hemostasis activation in COVID-19. Our study was to …
Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter Italian CORIST study
A Di Castelnuovo, S Costanzo… - Thrombosis and …, 2021 - thieme-connect.com
Introduction A hypercoagulable condition was described in patients with coronavirus
disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing …
disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing …
[HTML][HTML] Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial
AJ Gonzalez-Ochoa, JD Raffetto… - Thrombosis and …, 2021 - thieme-connect.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …
[HTML][HTML] Using automated machine learning to predict the mortality of patients with COVID-19: prediction model development study
K Ikemura, E Bellin, Y Yagi, H Billett, M Saada… - Journal of medical …, 2021 - jmir.org
Background During a pandemic, it is important for clinicians to stratify patients and decide
who receives limited medical resources. Machine learning models have been proposed to …
who receives limited medical resources. Machine learning models have been proposed to …
COVID-19, pre-eclampsia, and complement system
C Agostinis, A Mangogna, A Balduit… - Frontiers in …, 2021 - frontiersin.org
COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together
with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with …
with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with …
Clinical management of adult patients with COVID-19 outside intensive care units: guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian …
M Bassetti, DR Giacobbe, P Bruzzi, E Barisione… - Infectious Diseases and …, 2021 - Springer
Abstract Introduction The Italian Society of Anti-Infective Therapy (SITA) and the Italian
Society of Pulmonology (SIP) constituted an expert panel for developing evidence-based …
Society of Pulmonology (SIP) constituted an expert panel for developing evidence-based …
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study
WH Capell, ES Barnathan, G Piazza… - American heart …, 2021 - Elsevier
Background COVID-19 is associated with both venous and arterial thrombotic complications.
While prophylactic anticoagulation is now widely recommended for hospitalized patients …
While prophylactic anticoagulation is now widely recommended for hospitalized patients …